Table 3 Measures by EPIS phase and study aims

2

Reach (EPIS inner context)

•% WLHIV who had CC screening

Health records

Participant survey

2

Effectiveness (EPIS inner context)

•% WLHIV treated for preinvasive cancer who had negative posttreatment follow-up screening

Health records

Participant survey

2

Adoption

•% study sites that used AVIVA app to capture CC cases for real-time support

•% study sites that participated in the periodic review training sessions on CCST

•% study sites that initiated monthly educational meetings

•% study sites that participated in the quarterly stakeholder meetings

•% study sites that identified a referral coordinator to follow through with referred WLHIV with suspected cancer and ineligible lesions for treatment

•% study sites that distributed flyers/leaflets/flipcharts on CCST in clinics

•% study sites (Core+) that conducted HBI at support group meetings

•% study sites (Core+) that captured CCST data of recruited WLHIV on smart card

•% study sites (Core+) that send appointment reminders to patients using the mHealth platform

Survey

Documented records

2

Implementation strategy fidelity

•(QUANT) 7 items (for Core) and 11 items (for Core+) with subscales, degree that components of each strategy were implemented in terms of adherence, exposure, quality, and engagement

Survey

Documented records

Periodic reflection

2

CCST intervention fidelity (EPIS inner context)

•% WLHIV with preinvasive cancer eligible for treatment who had same-day treatment

•% WLHIV treated for preinvasive cancer who had posttreatment follow-up screening at 12 months

•% WLHIV with suspected cancer or lesions ineligible for treatment referred

Health records

Participant survey

2

Organizational readiness for CCST

•(QUANT) organizational readiness for implementation (ORIC)

Provider survey

2

Implementation climate (EPIS inner context)

•(QUANT) six items with three subscales, degree that CCST is expected, supported, and rewarded

Provider survey